For example, the combination of mTOR inhibitors with inhibitors of programmed cell death protein 1 (PD-1) or PD-L1 effectively reduced tumor growth in hepatocellular carcinoma [166]. Here, PDCD1 is linked to hepatocellular carcinoma.